Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25509852 | 0.84 | CA12 (0.53) | TSHRRECQLALDH1A1GAAMAPT | |
| SCHEMBL23292690 | 0.83 | RAB9A (0.57) | TSHRALDH1A1RAB9AKDM4EHSP90AA1 | |
| SCHEMBL14199943 | 0.81 | GAA (0.56) | TSHRALDH1A1RAB9AKDM4EHSP90AA1 | |
| SCHEMBL25494268 | 0.81 | RAB9A (0.51) | TSHRRECQLALDH1A1RAB9AKDM4E | |
| SCHEMBL25900637 | 0.80 | KMT2A (0.53) | RECQLALDH1A1RAB9AKDM4EHSP90AA1 | |
| SCHEMBL11693008 | 0.79 | MAPT (0.55) | TSHRRECQLALDH1A1RAB9AKDM4E | |
| SCHEMBL13449739 | 0.78 | CA12 (0.70) | ALDH1A1RAB9AGAACA12CA1 | |
| SCHEMBL25494284 | 0.77 | GAA (0.59) | ALDH1A1RAB9AKDM4EHSP90AA1GAA | |
| SCHEMBL10892785 | 0.77 | ALDH1A1 (0.55) | TSHRALDH1A1RAB9AKDM4EHSP90AA1 | |
| SCHEMBL13652644 | 0.77 | PKM (0.54) | TSHRALDH1A1RAB9AKDM4EHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158155-A1 | Cell Surface Receptor Binding Compounds and Conjugates | LYCIA THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158155-A1 | Cell Surface Receptor Binding Compounds and Conjugates | M6PR, ASGR1, IGF2R | TSHR 214/4885RECQL 4621/4885ALDH1A1 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.